Download Full Text (1022 KB)
Goal: To better understand drug resistance and sensitivity in patients with late stage (Stage III & IV) cancers that are receiving standard of care molecularly targeted therapies through next generation sequencing (NGS) of biopsy and blood samples collected longitudinally (diagnosis-- treatment--progression).
Maine Medical Center
Cancer Moonshot BioBank (CMB), Maine Cancer Genetics/Genomics Education Core (ME-CGEC), Cancer, Genomic Testing, Study Plan
Breggia, Anne C.; Miesfeldt, Sue; Korsen, Neil; Prescott, Jill; Lemire, Lisa; Searight, Meghan; Saunders, Jamie; and Remick, Scot, "The NCI/NIH Cancer Moonshot BioBank (CMB) and the Maine Cancer Genetics/Genomics Education Core (ME-CGEC) Collaborate to Improve Cancer Care in Maine" (2021). Costas T. Lambrew Research Retreat 2021. 55.